Cargando…
Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes
BACKGROUND: The clinical outcome of hypertrophic cardiomyopathy patients is not only determined by the disease-causing mutation but influenced by a variety of disease modifiers. Here, we defined the role of the mutation location and the mutant protein dose of the troponin T mutations I79N, R94C and...
Autores principales: | Schuldt, Maike, Johnston, Jamie R., He, Huan, Huurman, Roy, Pei, Jiayi, Harakalova, Magdalena, Poggesi, Corrado, Michels, Michelle, Kuster, Diederik W.D., Pinto, Jose R., van der Velden, Jolanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616699/ https://www.ncbi.nlm.nih.gov/pubmed/33148509 http://dx.doi.org/10.1016/j.yjmcc.2020.10.006 |
Ejemplares similares
-
The homozygous K280N troponin T mutation alters cross-bridge kinetics and energetics in human HCM
por: Piroddi, Nicoletta, et al.
Publicado: (2019) -
Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021) -
Diastolic myofilament dysfunction in the failing human heart
por: van der Velden, Jolanda
Publicado: (2011) -
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM
por: Pioner, Josè Manuel, et al.
Publicado: (2023) -
Sex-Related Differences in Protein Expression in Sarcomere Mutation-Positive Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)